Delhi HC restrains NPPA from action against AstraZeneca
The Delhi High Court has issued a temporary restraining order preventing the National Pharmaceutical Pricing Authority (NPPA) from taking action against AstraZeneca Pharma. The order will remain until the next hearing on January 11. AstraZeneca contends its inhaler product may not be subject to price controls, denying NPPA's allegations of overcharging from May 2016 to November 2025 and asserting compliance with pricing regulations.
Economic Times··Delhi




